| 标题 |
Reply to “Cost-Effectiveness of 177 Lu-PSMA-617 Versus Cabazitaxel: Accounting for Real-World and Health Equity Considerations” |
| 网址 | |
| DOI |
10.2967/jnumed.126.273360
doi
|
| 其它 |
期刊:Journal of Nuclear Medicine 作者:Kemal C. Gogebakan; Natalia Kunst; Alireza Ghodsi; Lukas Owens; Amir Iravani; et al 出版日期:2026-09-04 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)